The price of Applied Therapeutics Inc (NASDAQ: APLT) closed at $6.93 in the last session, up 4.68% from day before closing price of $6.62. In other words, the price has increased by $+0.31 from its previous closing price. On the day, 2099684 shares were traded.
Ratios:
We take a closer look at APLT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $12.
On January 04, 2022, Barclays Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $44 to $7.
Goldman Downgraded its Neutral to Sell on August 27, 2021, whereas the target price for the stock was revised from $16 to $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’23 when Kanter Stacy J. bought 30,000 shares for $2.18 per share. The transaction valued at 65,367 led to the insider holds 63,000 shares of the business.
Shendelman Shoshana sold 3,968 shares of APLT for $7,817 on Nov 30 ’23. The President and CEO now owns 2,596,387 shares after completing the transaction at $1.97 per share. On Nov 30 ’23, another insider, Perfetti Riccardo, who serves as the Chief Medical Officer of the company, sold 1,583 shares for $1.97 each. As a result, the insider received 3,119 and left with 692,341 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 733.80M and an Enterprise Value of 684.67M. For the stock, the TTM Price-to-Sale (P/S) ratio is 68.84. Its current Enterprise Value per Revenue stands at 68.52 whereas that against EBITDA is -10.67.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $9.39, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 3.87, while the 200-Day Moving Average is calculated to be 2.41.
Shares Statistics:
According to the various share statistics, APLT traded on average about 2.25M shares per day over the past 3-months and 3.03M shares per day over the past 10 days. A total of 84.87M shares are outstanding, with a floating share count of 73.95M. Insiders hold about 30.16% of the company’s shares, while institutions hold 56.10% stake in the company. Shares short for APLT as of Feb 15, 2024 were 3.87M with a Short Ratio of 1.72, compared to 3.63M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.01% and a Short% of Float of 5.96%.
Earnings Estimates
The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.23, while EPS last year was -$0.18. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.12 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.53 and -$1.21 for the fiscal current year, implying an average EPS of -$0.83. EPS for the following year is -$0.47, with 3 analysts recommending between -$0.25 and -$0.88.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for APLT’s current fiscal year. The highest revenue estimate was $17.2M, while the lowest revenue estimate was $6.28M, resulting in an average revenue estimate of $13.4M. In the same quarter a year ago, actual revenue was $9.99M, up 34.10% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $54.12M in the next fiscal year. The high estimate is $72.6M and the low estimate is $37.1M. The average revenue growth estimate for next year is up 303.90% from the average revenue estimate for this year.
